Singapore approved the Moderna (NASDAQ: MRNA) vaccine last week, marking another key milestone for the biotechnology company.
But Moderna was not the only company that deserves some credit.
The biotech firm had a huge helping hand from Veeva Systems (NASDAQ: VEEV), a software-as-a-service (SaaS) provider.
As the pandemic spread around the world, consumers turned to online video solutions such as Zoom (NASDAQ: ZM) to communicate.
Moderna, on the other hand, had to turn to business-based, online solutions by Veeva to conduct a clinical study involving over 30,000 participants in collaboration with multiple regulatory and government agencies.
Either way, cloud-based solutions are becoming more important in our daily lives, be it for personal or business use.